Atlas Trials

TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma

Clinical trial NCT04059224 · COMPLETED

Trial details

NCT number
NCT04059224
Sponsor
Universitair Ziekenhuis Brussel
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Stage IV MelanomaStage III Melanoma
Start date
2019-01-28
Primary completion
2023-06-30
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.